Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer

Anticancer Research

Volumn 24, Issue 3 B, 2004, Pages 1925-1928

  Shibata, Yoshihito ^a   Hidaka, Shigekazu ^a   Tagawa, Yutaka ^b   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bcl 2; Non small cell lung cancer; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3242726111     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Crai RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
2. Yonish-Rouach E, Resnizky D, Lotem J et al: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
3. Hollstein M, Sidranski D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
4. Wang Y, Szekely L, Okan I, Klein G and Wiman KG: Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a c-myc-induced T-cell lymphoma line. Oncogene 8: 3427-3431, 1993.
5. Tsujimoto Y, Cossman J, Jaffe E and Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443, 1985.
6. Mitsudomi T, Oyama T, Kusano T et al: Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small cell cancer. J Natl Cancer Inst 85: 2018-2023, 1993.
7. Quinlan DC, Davidson AG, Summers CL, Warden HE and Doshi HM: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52: 4828-4831, 1992.
8. Pezzela F, Turley H, Kuzu I et al: Bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 329: 690-694,1993.
9. World Health Organization: The World Health Organization. Histological typing of lung tumours. Am J Clin Pathol 77: 123-136, 1982
10. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1711-1717, 1997.
11. Groeger AM, Caputi M, Esposito V, Luca A et al: Bcl-2 protein expression correlates with nodal status in non small cell lung cancer. Anticancer Res 19: 821-824,1999.
12. Ruay-Sheng L, Jyh-Seng W, Hon-ki H et al: Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer. Jpn J Clin Oncol 32: 393-397, 2002.
13. Holmgren L, O'Reilly MS and Folkman J: Dormancy of micrometastasis: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153, 1995.
14. Manfred V and Reet K: The implications of proliferation and apoptosis for lung cancer metastasis. Oncol Rep 6: 373-376, 1999.
15. Fontanini G, Vignati S, Bigini D et al: Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 71: 1003-1007, 1995.
16. Chen Y, Sato M, Fujimura S et al: Expression of bcl-2, bax, and p53 proteins in carcinogenesis of squamous cell lung cancer. Anticancer Res 19: 1351-1356, 1999.
17. Apolinario RM, Van Der Valk P, de Jong JS et al: Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol 15: 2456-2466, 1997.
18. D'Amico TA, Massey M, Herndon JE, Moore MB and Harpole Jr DH: A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 117: 736-743, 1999.
19. Chris IH, Donna N, Bruce E, Jeanne YW and David CC: Expression of bcl-2 protein is associated with shorter survival in non-small cell lung carcinoma. Cancer 98: 135-143, 2003.
20. Kim YC, Park KO, Kern JA et al: The interactive effect of Ras, HER2, p53 and bcl-2 expression in predicting the survival of non-small cell lung cancer patients. Lung Cancer 22: 181-190, 1998.
21. Martin B, Paesmans M, Berghmans T et al: Role of bcl-2 as a prognostic factor for survival in lung cancer. A systematic review of the literature with meta-analysis. Br J Cancer 89: 55-64, 2003.